RxDoctor Payments Data

Jillian Monticciolo

Physician Assistant · Sterling Hts, MINPI 1861949950

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 967 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,436in general payments, 2019–2025

Across 967 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • AstraZeneca$1K
  • Amgen$1K
  • Lilly USA, LLC$1K
  • Pfizer$895
  • plus $6K from 36 others

What the payments were for

  • Food & beverage$14,405100%
  • Education$310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,436 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol42$55,688
OzempicSemaglutide25$42,572
MounjaroTirzepatide34$42,279
JardianceEmpagliflozin22$36,955
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$27,076
XareltoRivaroxaban14$19,004
Repatha SureclickEvolocumab13$16,748
EliquisApixaban15$16,685
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$9,606
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen140$4,905
AbrysvoRsv Vacc, Pref A And Pref B/Pf14$4,474
Lubiprostone11$2,646
Gabapentin62$1,806
Rosuvastatin Calcium72$1,559
Atorvastatin Calcium114$1,515

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,416$65,29453 claims
Novo NordiskOzempic$1,865$42,57225 claims
Lilly USA, LLCMounjaro$1,090$42,27934 claims
Boehringer IngelheimJardiance$500$36,95522 claims
GSKTrelegy Ellipta$436$27,07621 claims
PfizerEliquis, Abrysvo$895$21,15929 claims
Johnson & JohnsonXarelto$97$19,00414 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$46$1,09667 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Sterling Hts

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →